Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives
- 166 Downloads
A series of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives (5a–o) were synthesized and screened for inhibitory activity against Mycobacterium tuberculosis H37Ra (ATCC 25177) and Mycobacterium bovis BCG (ATCC 35743) strains. Five lead compounds (5e, 5f, 5g, 5h, and 5o) were further confirmed from their dose dependent effect against MTB and Bovine–Calmette–Guerin. The most promising compounds 5f (MIC90: 11.32 µg/mL), 5h (MIC90: 11.59 µg/mL), and 5o (MIC90: 23.64 µg/mL) showed strong antitubercular activity against dormant MTB and BCG as well as almost insignificant cytotoxicity up to 100 µg/mL against HeLa, A549, and PANC-1 human cancer cell lines. Further, the synthesized compounds were found to have potential antibacterial activity against Gram-negative bacteria, Escherichia coli, Pseudomonas flurescence and Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis. Most of the synthesized compounds showed moderate activity against fungal strain Candida albicans. Molecular docking studies of these compounds showed significant interactions with crystal structure of the cytochrome P45014α-sterol demethylase (CYP51) PDB ID: 1E9X. Hydrogen bond interactions with SER261 and VAL395 are important interactions for selective inhibition of designed inhibitors. Compounds 5f, 5h, and 5o showed significant interactions with 1E9X. All the experimental results promote us to consider this series as a starting point for the development of novel, selective and more potent antitubercular agents in the future.
KeywordsBisthiazoles Mycobacterium tuberculosis Antimicrobial activity Cytotoxicity Docking study
YKA expresses her gratefulness to CSIR [File No. 08/590(0001)/2012-EMR-I] for the financial support. PCM would like to thank University Grant Commission (UGC No. 42-355(SR)/2013), New Delhi, India for the financial assistance and CSIR-NCL, Pune for supporting biological activity. Central Analysis facility, Savitribai Phule Pune University, Pune is also acknowledged for spectral analysis.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Alvarez G, Martinez J, Varela J, Birriel E, Cruces E, Gabay M, Leal SM, Escobar P, Aguirre-Lopez B, Cabrera N, Tuena de Gomez-Puyou M, Gomez PA, Perez-Montfort R, Yaluff G, Torres S, Serna E, Vera de Bilbao N, Gonzalez M, Cerecetto H (2015) Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo. Eur J Med Chem 100:246–256CrossRefPubMedGoogle Scholar
- Araniciu C, Marutescu L, Oniga S, Oniga O, Chifiriuc MC, Palage M (2014a) Evaluation of the antimicrobial and anti-biofilm activity of some 4,2 and 5,2 bisthiazoles derivatives. Dig J Nanomater Biostruct 9:123–131Google Scholar
- Araniciu C, Parvu AE, Tiperciuc B, Palage M, Oniga S, Verite P, Oniga O (2013) Synthesis and evaluation of the anti-inflammatory activity of some 2-(trimethoxyphenyl)-4-R1-5-R2-thiazoles. Dig J Nanomater Bios 8:699–709Google Scholar
- Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O’Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of america: treatment of tuberculosis. Am J Respir Crit Care Med 167(4):603–662CrossRefPubMedGoogle Scholar
- Inamdar GS, Pandya AN, Thakar HM, Sudarsanam V, Kachler S, Sabbadin D, Moro S, Klotz KN, Vasu KK (2013) New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides. Eur J Med Chem 63:924–934CrossRefPubMedGoogle Scholar
- Johnson M, Antonio T, Reith ME, Dutta AK (2012) Structure–activity relationship study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogs: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization. J Med Chem 55:5826–5840CrossRefPubMedPubMedCentralGoogle Scholar
- Leelabai MS, Dinesh AS, Abbs F, Kallikat RN (2008) Synthesis of novel 1,4-bis[(5-aroyl-2-N,N-disubstituted amino)thiazol-4-yl]benzenes. ARKIVOC 15:288–296Google Scholar
- Patravale AA, Gore AH, Kolekar GB, Deshmukh MB, Choudhari PB, Bhatia MS, Prabhu S, Jamdhade MD, Patole MS, Anbhule PV (2016) Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents. J Taiwan Inst Chem Eng 68:105–118CrossRefGoogle Scholar
- Tomasic T, Katsamakas S, Hodnik Z, Ilas J, Brvar M, Solmajer T, Montalvao S, Tammela P, Banjanac M, Ergovic G, Anderluh M, Masic LP, Kikelj D (2015) Discovery of 4,5,6,7-tetrahydrobenzo[1,2-d]thiazoles as novel DNA gyrase inhibitors targeting the ATP-binding site. J Med Chem 58:5501–5521CrossRefPubMedGoogle Scholar
- WHO Tuberculosis Fact Sheet (2016) http://www.who.int/mediacentre/factsheets/fs104/en/Google Scholar